DS
TMDX icon

David Shaw’s Transmedics TMDX Stock Holding History

David Shaw’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-60,000
Closed -$6.73M – 5011
2025
Q3 		$6.73M Buy
+60,000
New +$7.02M ﹤0.01% 1973

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

David Shaw's TMDX Position: Q2 2026 in Review

David Shaw sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 2,481 shares — an estimated $210K sold.

David Shaw first reported a position in TMDX in Q3 2022 and held it in 11 quarters. The position peaked at $33.5M in Q1 2023. 371 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • David Shaw reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
  • David Shaw sold 2,481 Transmedics shares in Q2 2026, an estimated $210K.
  • David Shaw first reported a position in Transmedics in Q3 2022 and held it in 11 quarters.
  • David Shaw's Transmedics position peaked at $33.5M in Q1 2023.
  • 371 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.